Radius Ventures

Radius Ventures is a New York-based venture capital firm with a dedicated focus on the healthcare and life sciences sectors. Established in 1997, the firm has built a reputation for investing in companies that are developing and commercializing innovative products and services aimed at improving healthcare quality and reducing costs. Their investment scope spans across biopharmaceuticals, medical devices, diagnostics, and healthcare services/IT, targeting both early-stage and growth-stage companies.

The firm's investment strategy emphasizes identifying companies with strong management teams, proprietary technologies, and significant market opportunities. Radius Ventures typically provides initial investments ranging from $5 million to $20 million, demonstrating their commitment to substantial capital deployment for promising ventures. They also reserve capital for follow-on investments, which can bring their total commitment to a single company up to $30 million, supporting portfolio companies through various stages of their development and growth.

Over its more than two-decade history, Radius Ventures has successfully raised and managed five distinct funds. Their most recent fund, Radius Ventures V, L.P., closed at $250 million in 2011, contributing to a cumulative total of $700 million in capital under management across all their funds. The firm has invested in over 60 companies, showcasing a broad and diversified portfolio within the healthcare innovation landscape. This extensive experience underscores their deep expertise and network within the specialized sectors they serve.